Centurium Capital Acquires Controlling Stake in Beijing Jingdu Children’s Hospital2020-08-12
August 12, 2020, Beijing – Centurium Capital (“Centurium”), a leading private equity investment firm in China, announced today that it has acquired a controlling stake in Beijing Jingdu Children’s Hospital (“Jingdu”). Located in Changping District in northern Beijing, Jingdu is the largest private children’s hospital in China and the only private tertiary children’s hospital in Beijing.
Launched in June 2015 and located on a 40,000 square meter premises, Jingdu has 36 specialized departments, including an emergency center, and is a recognized leader in children’s hematology, cardiology, dermatology, and stomatology. Jingdu officially became a designated medical institution for Beijing Medical Insurance Plan in 2017.
In July 2020, Jingdu was awarded the Joint Commission International (JCI) accreditation with top marks, becoming the first children’s specialty hospital in China to pass the JCI review via online virtual inspection and evaluation. The JCI accreditation is recognized as a global leader for health care quality and patient safety.
Zhixing Chen, Executive Director of Centurium Capital, commented, “As the largest private tertiary children’s hospital in China, Jingdu has become a leading children’s specialty health services platform, and it has accumulated extensive medical resources and service capabilities. We highly value Jingdu’s brand and professionalism, and firmly believe Jingdu will further solidify its leadership in the industry through continued investment in its medical team and service quality.”
Healthcare is one of the key investment sectors for Centurium. Previously, Centurium has made investments in two other hospitals in China, namely the UIB Group and Beijing Arion Cancer Hospital. Headquartered in Shanghai, UIB Group is a top-tier children and women’s medical services group with a children’s hospital, an obstetrics and gynecology (OBGYN) hospital, and a postpartum center. Arion Cancer Hospital is currently under construction and expected to open by the end of 2020.
Strategically located in the densely-populated Huilongguan-Tiantongyuan area of the Changping District, Jingdu is the only children’s hospital in the district. Driven by its premium medical facilities and services, it treats nearly 300,000 outpatients and 8,000 inpatients a year.
Thanks to its track-record of professionalism and leading research contributions, Jingdu has demonstrated strong business resilience and steady growth despite the impact of Covid-19 pandemic.